Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

Author(s): Liangkun You, Changyu Liu, Hexiao Tang, Yongde Liao, Shengling Fu

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 17 , 2014

Become EABM
Become Reviewer
Call for Editor


Insulin-like growth factors (IGFs), along with their receptors and binding proteins, play key roles in human cell proliferation, differentiation and apoptosis. There is now substantial evidence suggesting that the IGF system is involved in the pathogenesis and progression of various malignancies. Recent studies have shown that targeting of the IGF-1 receptor (IGF-1R) signaling pathway might be a novel approach for the treatment of cancer. Presently numerous agents featuring different mechanisms of IGF targeting methods such as IGF-1R monoclonal antibodies, IGF-1R tyrosine kinase inhibitors and IGF ligand specific antibodies are being investigated in more than 170 clinical trials and appear to have potential therapeutic efficacy. However, advanced trials reiterate the importance of predictive biomarkers to guide the clinical efforts of these agents. As a result, current research strategies are emerging to identify the most suitable subpopulations of patients that might benefit from these treatments. Furthermore, newly presented toxicity and growth hormone response and implication of hybrid receptors in IGF signaling pathway pose unprecedented challenges in the design and application of anti-IGF agents. On the other hand, cross-talk in downstream signaling between IGF-1R and other tumor promoting pathways and the development of multi-target agents might encourage the IGF-1R-targeted therapies further into comprehensive treatments of cancer. With both challenges and prospects ahead, this paper reviewed the progress in this particular field.

Keywords: Insulin-like growth factor, insulin-like growth factor receptor, targeted therapy, cancer.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 11 August, 2013
Page: [2899 - 2911]
Pages: 13
DOI: 10.2174/13816128113199990595
Price: $65

Article Metrics

PDF: 80